Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Viking Therapeutics coming to eat Eli Lilly and Novo Nordisk's lunch, Hims & Hers moving up hard, Zoom with a strong outlook, and Unity still failing to impress. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the NFL Combine and the Buccaneers. Stay on the cutting edge with Rebel's Edge